Ophthalmology veteran Jim Mazzo has led compa...
The election of Donald Trump had an immediate...
This has been a busy year for Thomas Frinzi, ...
Carl Zeiss Meditec continues to add top talen...
Three-year-old TearSolutions hopes to pen a s...
KOLs, CEOs, and analysts say Ophthotech’s d...
EyeGate CEO Stephen From reports positive res...
Christian Roesky, PhD, joins the OIS Podcast ...
The threat of Medicare clamping down on drug ...
Frederic Guerard, head of Novartis’ ophthal...